Chunying J. Cui

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure

Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: June 29, 2026

UCHL3 drives ferroptosis in nucleus pulposus cells by deubiquitinating HMGB1 to activate NCOA4-mediated ferritinophagy.

UCHL3 drives ferroptosis in nucleus pulposus cells by deubiquitinating HMGB1 to activate NCOA4-mediated ferritinophagy.

Journal: Autophagy

Published: May 22, 2026

Mosaic DICER1 RNase IIIb hotspot mutation with multiple tumors: case report and literature review.

Mosaic DICER1 RNase IIIb hotspot mutation with multiple tumors: case report and literature review.

Journal: Frontiers in oncology

Published: December 30, 2025

Identification of coilin in bone marrow as a potential neuroblastoma tumor progression marker transcriptionally regulated by MYCN.

Identification of coilin in bone marrow as a potential neuroblastoma tumor progression marker transcriptionally regulated by MYCN.

Journal: Cancer biology & therapy

Published: December 22, 2025

Efficacy and safety of dinutuximab beta combined with GM-CSF and isotretinoin ± chemotherapy as first-line maintenance treatment for pediatric high-risk neuroblastoma in China.

Efficacy and safety of dinutuximab beta combined with GM-CSF and isotretinoin ± chemotherapy as first-line maintenance treatment for pediatric high-risk neuroblastoma in China.

Journal: Frontiers in oncology

Published: December 11, 2025

An innovative and stable mRNA-LNP microneedle vaccine elicits humoral and multifunctional cellular immune responses.

An innovative and stable mRNA-LNP microneedle vaccine elicits humoral and multifunctional cellular immune responses.

Journal: Acta pharmaceutica Sinica. B

Published: March 03, 2025

A case of chronic hepatitis B with low-level viremia treated with tenofovir amibufenamide

A case of chronic hepatitis B with low-level viremia treated with tenofovir amibufenamide

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: February 19, 2025

High-Density Lipoprotein Biomimetic Inorganic-Organic Composite Nanosystem for Atherosclerosis Therapy.

High-Density Lipoprotein Biomimetic Inorganic-Organic Composite Nanosystem for Atherosclerosis Therapy.

Journal: Polymers

Published: January 24, 2025

Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy.

Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy.

Journal: Journal of nanobiotechnology

Published: January 08, 2025

Engineered Hollow Nanocomplex Combining Photothermal and Antioxidant Strategies for Targeted Tregs Depletion and Potent Immune Activation in Tumor Immunotherapy.

Engineered Hollow Nanocomplex Combining Photothermal and Antioxidant Strategies for Targeted Tregs Depletion and Potent Immune Activation in Tumor Immunotherapy.

Journal: Advanced healthcare materials

Published: December 18, 2024

NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy.

NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy.

Journal: International journal of nanomedicine

Published: December 11, 2024

MMP-2 Responsive Gold Nanorods Loaded with HSP-70 siRNA for Enhanced Photothermal Tumor Therapy.

MMP-2 Responsive Gold Nanorods Loaded with HSP-70 siRNA for Enhanced Photothermal Tumor Therapy.

Journal: Molecular pharmaceutics

Published: October 18, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026